Effects of Linagliptin on Endothelial- , Renal-, and Retinal Function in Comparison to Placebo in Patients with Hypertension and Albuminuria
Phase of Trial: Phase III
Latest Information Update: 01 Nov 2018
At a glance
- Drugs Linagliptin (Primary)
- Indications Hypertension; Proteinuria
- Focus Pharmacodynamics; Registrational
- 31 Aug 2018 Biomarkers information updated
- 09 Jun 2015 Primary endpoint has not been met. (Albumin/Creatinine Ratio (UACR) in 24h urine change between Baseline and Visit 4) as per abstract presented at 75th Annual Scientific Sessions of the American Diabetes Association.
- 09 Jun 2015 Results presented at the 75th Annual Scientific Sessions of the American Diabetes Association.